Ferdinandos Skoulidis, MD, PhD, explores emerging KRAS-targeted therapies in KRAS-mutated non–small cell lung cancer.
Ferdinandos Skoulidis, MD, PhD
Advertisement
Ferdinandos Skoulidis MD, PhD, is a professor of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center.
Articles by Ferdinandos Skoulidis, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Onc
1
Lonardi on Overall Survival With Nivolumab/Ipilimumab in MSI-H/dMMR mCRC
2
FDA Approves Generic Venetoclax Tablets for CLL/SLL and AML
3
JNJ-6143 Elicits PSA Responses in Heavily Pretreated mCRPC
4
Geron Halts Phase 3 IMpactMF Trial of Imetelstat in R/R Myelofibrosis
5